Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure

The prognosis for patients with myelodysplastic syndrome with hypomethylating treatment failure (MDS-HTF) has been known to be poor. However, the clinical outcomes and optimal treatment options for secondary AML evolving from MDS-HTF (sAML/MDS-HTF) are not well known. This retrospective analysis was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone marrow transplantation (Basingstoke) 2013-05, Vol.48 (5), p.678-683
Hauptverfasser: Shin, S-H, Yahng, S-A, Yoon, J-H, Lee, S-E, Cho, B-S, Eom, K-S, Lee, S, Min, C-K, Kim, H-J, Cho, S-G, Kim, D-W, Lee, J-W, Min, W-S, Park, C-W, Kim, Y-J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!